---
figid: PMC7493839__12935_2020_1546_Fig2_HTML
figtitle: The CRISPR-Cas9 complex and its mechanism of action in presence of target
  DNA
organisms:
- Escherichia coli K-12
- Streptococcus pyogenes
- Synechocystis sp.
- Legionella pneumophila
- Thermus thermophilus
- Streptococcus agalactiae
- Rhodococcus jostii RHA1
- Marinomonas mediterranea
- Thioalkalivibrio sp.
- Shewanella putrefaciens CN-32
- Rippkaea orientalis PCC 8801
- Neisseria lactamica 020-06
- Bacillus thuringiensis HD-771
- Ruminococcus sp. N15.MGS-57
- Candidatus Micrarchaeum sp. ARMAN-1
- Oleiphilus sp.
- Francisella cf. novicida Fx1
- Hepatitis B virus
- Human papillomavirus
- Human papillomavirus type 16
- Human alphaherpesvirus 2
- Homo sapiens
- Mus musculus
- Molva molva
- uncultured Cyanothece sp.
- NA
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC7493839
filename: 12935_2020_1546_Fig2_HTML.jpg
figlink: pmc/articles/PMC7493839/figure/Fig2/
number: F2
caption: Schematic overview of the CRISPR-Cas9 complex and its mechanism of action
  in presence of target DNA. a Compartments of CRISPR-Cas9 complex bound to the target
  double-stranded DNA and sgRNA. Watson–Crick base pairing between target DNA and
  sgRNA leads Cas9 to the site of reaction. DNA DSB occurs at three nucleotides upstream
  of PAM motif (brown) by incorporation of HNH and RuvC domains. b Non-homologous
  end joining (NHEJ) repairing pathway and some of its consequences. NHEJ introduces
  indels (insertion/deletion) among target DNA and results in frameshift or loss of
  function inducement. c homology-directed repair (HDR) pathway and some of its after-effects.
  In presence of a donor template, which is flanked by sequences complement to target
  DNA, the reaction directs toward the HDR pathway, leading to precise insertion or
  edition
papertitle: CRISPR-Cas, a robust gene-editing technology in the era of modern cancer
  immunotherapy.
reftext: Seyed Mohammad Miri, et al. Cancer Cell Int. 2020;20:456.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8397973
figid_alias: PMC7493839__F2
figtype: Figure
redirect_from: /figures/PMC7493839__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7493839__12935_2020_1546_Fig2_HTML.html
  '@type': Dataset
  description: Schematic overview of the CRISPR-Cas9 complex and its mechanism of
    action in presence of target DNA. a Compartments of CRISPR-Cas9 complex bound
    to the target double-stranded DNA and sgRNA. Watson–Crick base pairing between
    target DNA and sgRNA leads Cas9 to the site of reaction. DNA DSB occurs at three
    nucleotides upstream of PAM motif (brown) by incorporation of HNH and RuvC domains.
    b Non-homologous end joining (NHEJ) repairing pathway and some of its consequences.
    NHEJ introduces indels (insertion/deletion) among target DNA and results in frameshift
    or loss of function inducement. c homology-directed repair (HDR) pathway and some
    of its after-effects. In presence of a donor template, which is flanked by sequences
    complement to target DNA, the reaction directs toward the HDR pathway, leading
    to precise insertion or edition
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT1S1
  - PAM
  - MYCBP2
  - GATA3
  - ULK4P3
  - ULK4P1
  - ULK4P2
  - rec
  - bh
  - kst
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - pi
  - mid
  - pnt
  - Rpn3
  - Dox-3
  - dx
  - DOX
  - DX
  - ID
---
